Literature DB >> 21742108

Long-term results of atrial fibrillation ablation: the importance of all initial ablation failures undergoing a repeat ablation.

Roger A Winkle1, R Hardwin Mead, Gregory Engel, Rob A Patrawala.   

Abstract

BACKGROUND: Ablation is more successful for patients with paroxysmal atrial fibrillation (AF1) than for those with persistent (AF2) or longstanding persistent AF (AF3). Many patients fail initial ablation and undergo repeat ablations. Little is known about repeat ablation procedure times, complications, and outcomes.
METHODS: We evaluated Kaplan-Meier freedom from AF by AF type and sex for initial and repeat ablations and for final status of 843 patients undergoing 1122 ablations. We examined complications, procedure times and reasons why patients do not undergo repeat ablations. Cox multivariate analysis evaluated factors predicting ablation failure.
RESULTS: Initial ablations were more successful in AF1 than AF2 or AF3 (P < .0001) patients. For each AF type, repeat ablations were more successful than initial ablations (P = .01 to <.001). Procedure times (139.1 ± 49.1 vs 135.3 ± 45.6 minutes, P = .248) and major complications (1.66% vs 2.87%, P = .216) were similar. Women had different clinical characteristics than men, similar initial and repeat ablation success rates but lower overall success because of fewer repeat ablations (57.8% vs 68.2%, P = .047) due to patient choice (P = .028). Patients with either successful initial ablations or undergoing repeat ablations had late AF recurrence rates of 0% to 1.5% a year. Age (P = .012), larger left atria (P = .002), female sex (P = .001), AF2 (P < .0001), AF3 (P = .003), and coronary disease (P = .003) predicted failure.
CONCLUSIONS: Repeat ablations are more successful than initial ablations, have similar procedure times and complication rates, help determine final success rates, and may explain sex difference in success rates. For the best outcomes, patients should assume that a repeat ablation may be required to eliminate AF.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21742108     DOI: 10.1016/j.ahj.2011.04.013

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  23 in total

Review 1.  Predictors of Recurrence After Radiofrequency Ablation of Persistent Atrial Fibrillation.

Authors:  Miki Yokokawa; Hakan Oral; Aman Chugh
Journal:  J Atr Fibrillation       Date:  2012-10-06

Review 2.  Necessity of Repeat Ablations to Eliminate Atrial Fibrillation.

Authors:  Stephanie Fichtner; Gabriele Hessling; Isabel Deisenhofer
Journal:  J Atr Fibrillation       Date:  2012-02-02

3.  Outcomes of a comprehensive strategy during repeat atrial fibrillation ablation.

Authors:  Willy Weng; David H Birnie; F Daniel Ramirez; Cassidy Van Stiphout; Mehrdad Golian; Pablo B Nery; Simon P Hansom; Calum J Redpath; Andres Klein; Girish M Nair; Wael Alqarawi; Martin S Green; Darryl R Davis; Pasquale Santangeli; Robert D Schaller; Francis E Marchlinski; Mouhannad M Sadek
Journal:  J Interv Card Electrophysiol       Date:  2022-04-03       Impact factor: 1.900

4.  Increased Susceptibility to Atrial Fibrillation Secondary to Atrial Fibrosis in Transgenic Goats Expressing Transforming Growth Factor-β1.

Authors:  Irina A Polejaeva; Ravi Ranjan; Christopher J Davies; Misha Regouski; Justin Hall; Aaron L Olsen; Qinggang Meng; Heloisa M Rutigliano; Derek J Dosdall; Nathan A Angel; Frank B Sachse; Thomas Seidel; Aaron J Thomas; Rusty Stott; Kip E Panter; Pamela M Lee; Arnaud J Van Wettere; John R Stevens; Zhongde Wang; Rob S MacLeod; Nassir F Marrouche; Kenneth L White
Journal:  J Cardiovasc Electrophysiol       Date:  2016-08-30

5.  The mechanism of mitral regurgitation assessed by preprocedural echocardiography is associated with the outcome of catheter ablation in patients with paroxysmal atrial fibrillation.

Authors:  Masateru Takigawa; Taishi Kuwahara; Atsushi Takahashi; Kenji Okubo; Emiko Nakashima; Yuji Watari; Kazuya Yamao; Jun Nakajima; Yasuaki Tanaka; Katsumasa Takagi; Shigeki Kimura; Hiroyuki Hikita; Kenzo Hirao; Mitsuaki Isobe
Journal:  J Interv Card Electrophysiol       Date:  2016-03-15       Impact factor: 1.900

Review 6.  Gene Therapy for Cardiac Arrhythmias.

Authors:  Tetsuo Sasano; Kentaro Takahashi; Koji Sugiyama
Journal:  Acta Cardiol Sin       Date:  2013-05       Impact factor: 2.672

7.  Trends in atrial fibrillation ablation: have we maximized the current paradigms?

Authors:  Roger A Winkle; R Hardwin Mead; Gregory Engel; Melissa H Kong; Rob A Patrawala
Journal:  J Interv Card Electrophysiol       Date:  2012-02-28       Impact factor: 1.900

8.  Safety and patient-reported outcomes in index ablation versus repeat ablation in atrial fibrillation: insights from the German Ablation Registry.

Authors:  Shinwan Kany; Johannes Brachmann; Thorsten Lewalter; Karl-Heinz Kuck; Dietrich Andresen; Stephan Willems; Ellen Hoffmann; Lars Eckardt; Dierk Thomas; Matthias Hochadel; Jochen Senges; Andreas Metzner; Andreas Rillig
Journal:  Clin Res Cardiol       Date:  2020-10-28       Impact factor: 5.460

Review 9.  Long-term outcomes of catheter ablation of atrial fibrillation: a systematic review and meta-analysis.

Authors:  Anand N Ganesan; Nicholas J Shipp; Anthony G Brooks; Pawel Kuklik; Dennis H Lau; Han S Lim; Thomas Sullivan; Kurt C Roberts-Thomson; Prashanthan Sanders
Journal:  J Am Heart Assoc       Date:  2013-03-18       Impact factor: 5.501

10.  Physician-controlled costs: the choice of equipment used for atrial fibrillation ablation.

Authors:  Roger A Winkle; R Hardwin Mead; Gregory Engel; Melissa H Kong; Rob A Patrawala
Journal:  J Interv Card Electrophysiol       Date:  2013-03-14       Impact factor: 1.900

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.